Filing Flows › Phathom Pharmaceuticals (PHAT) › How it makes money
How Phathom Pharmaceuticals (PHAT) makes money
Phathom Pharmaceuticals (PHAT) made $84.7M of revenue in the third quarter 2026 (Q3 2026), +71% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $84.7M | 100.0% |
| Operating cash flow | $1.8M | 2.2% |
| Free cash flow | $1.7M | 2.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $84.7M | +71% |
| Q2 2026 | $74.3M | +88% |
| Q1 2026 | $58.3M | +104% |
| Q4 2025 | $57.6M | +94% |
| Q3 2025 | $49.5M | +203% |
| Q2 2025 | $39.5M | +439% |
| Q1 2025 | $28.5M | 15× |
From Phathom Pharmaceuticals' 10-Q filed Oct 29, 2026 (on EDGAR).
Questions
How does Phathom Pharmaceuticals make money?
Phathom Pharmaceuticals (PHAT) made $84.7M of revenue in the third quarter 2026 (Q3 2026), +71% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.